Trial intelligence / Profile preview

Doxycycline vs Levofloxacin for H. pylori Eradication

NCT04348786Phase 4Completed

Sponsor
Damascus Hospital
Start
Feb 2019
Primary completion
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of doxycycline in Helicobacter pylori infection (2 arms), sponsored by Damascus Hospital. Primary endpoint: Eradication rate of Helicobacter pylori infection at 8 weeks. Started Feb 2019; status: completed.

02

Drugs

doxycycline
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT04348786.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04348786.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call